Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
Singh AK, Misra A, Das AK, Behl A, Srivastava A, Paneerselvam A, Chidambaram B, Saboo B, Sethi B, Makkar BM, Bantwal G, Thacker H, Panda J, Kesavadev J, Seshadri KG, Tiwaskar M, Shunmugavelu M, Sahay R, Das S, Agarwal S, Shaikh S, Sharma SK, Gupta S, Bhattacharyya S, Mohan V, Gunupati VK. Singh AK, et al. Among authors: gupta s. J Assoc Physicians India. 2023 Dec;71(12):62-74. doi: 10.59556/japi.71.0422. J Assoc Physicians India. 2023. PMID: 38736056
Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis.
Kovil R, Chawla M, Shah T, Sahoo A, Makkar B, Kesavadev J, Seshadri K, Tiwaskar M, Rajput R, Phatak S, Majumdar S, Gupta S. Kovil R, et al. Among authors: gupta s. J Assoc Physicians India. 2022 Aug;70(8):11-12. doi: 10.5005/japi-11001-0076. J Assoc Physicians India. 2022. PMID: 36082726
Prescribing Patterns and Response to Antihyperglycemic Agents Among Novel Clusters of Type 2 Diabetes in Asian Indians.
Anjana RM, Siddiqui MK, Jebarani S, Vignesh MA, Kamal Raj N, Unnikrishnan R, Pradeepa R, Panikar VK, Kesavadev J, Saboo B, Gupta S, Sosale AR, Seshadri KG, Deshpande N, Chawla M, Chawla P, Das S, Behera M, Chawla R, Nigam A, Gupta A, Kovil R, Joshi SR, Agarwal S, Bajaj S, Pearson ER, Doney ASF, Palmer CNA, Mohan V. Anjana RM, et al. Among authors: gupta a, gupta s. Diabetes Technol Ther. 2022 Mar;24(3):190-200. doi: 10.1089/dia.2021.0277. Epub 2022 Jan 5. Diabetes Technol Ther. 2022. PMID: 34609928
Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion.
Das AK, Gandhi P, Saboo B, Reddy S, Chawla R, Zargar AH, Kovil R, Chawla M, Sharma SK, Gupta S, Makkar BM, Mittal V, Goswami S, Arvind SR, Jaggi S, Bajaj S, Das S. Das AK, et al. Among authors: gupta s. J Family Med Prim Care. 2021 Dec;10(12):4398-4409. doi: 10.4103/jfmpc.jfmpc_2378_20. Epub 2021 Dec 27. J Family Med Prim Care. 2021. PMID: 35280631 Free PMC article. Review.
REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study.
Saboo B, Agarwal S, Gupta S, Makkar B, Panneerselvam A, Sahoo AK, Ramchandani GD, Das S, Erande S, Kadam Y, Abhyankar MV, Revankar S. Saboo B, et al. Among authors: gupta s. J Family Med Prim Care. 2021 Sep;10(9):3444-3452. doi: 10.4103/jfmpc.jfmpc_2010_20. Epub 2021 Sep 30. J Family Med Prim Care. 2021. PMID: 34760771 Free PMC article.
Clinical Profile of Long-Term Survivors and Nonsurvivors with Type 1 Diabetes in India.
Mohan V, Shanthi Rani CS, Saboo B, Mukhopadhyay S, Chatterjee S, Dharmarajan P, Gupta S, Pendsey S, Chandrakanta J, Umasankari G, Amutha A, Salis S, Datta S, Gupta PK, Routray P, Jebarani S, Sastry NG, Venkatesan U, Anjana RM, Unnikrishnan R. Mohan V, et al. Among authors: gupta s, gupta pk. Diabetes Technol Ther. 2022 Feb;24(2):120-129. doi: 10.1089/dia.2021.0284. Epub 2021 Dec 15. Diabetes Technol Ther. 2022. PMID: 34569820
23,603 results
You have reached the last available page of results. Please see the User Guide for more information.